JG
NXTM

Jefferies Group’s NxStage Medical Inc. NXTM Stock Holding History

Jefferies Group’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-13,666
Closed -$391K – 2838
2018
Q4 		$391K Sell
13,666
-200
-1% -$5.68K ﹤0.01% 1559
2018
Q3 		$387K Buy
13,866
+200
+1% +$5.63K ﹤0.01% 1743
2018
Q2 		$381K Sell
13,666
-200
-1% -$5.36K ﹤0.01% 1734
2018
Q1 		$345K Sell
13,866
-11,200
-45% -$272K ﹤0.01% 1720
2017
Q4 		$607K Sell
25,066
-113,302
-82% -$2.99M ﹤0.01% 1635
2017
Q3 		$3.82M Buy
+138,368
New +$3.69M 0.03% 638
2017
Q2 		– Sell
-8,228
Closed -$221K – 2770
2017
Q1 		$221K Buy
+8,228
New +$227K ﹤0.01% 1991
2015
Q4 		– Sell
-53,672
Closed -$847K – 2698
2015
Q3 		$847K Buy
53,672
+53,593
+67,839% +$859K ﹤0.01% 1279
2015
Q2 		$1K Buy
+79
New +$1.34K ﹤0.01% 3241

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Jefferies Group's NXTM Position: Q1 2019 in Review

Jefferies Group sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 13,666 shares — an estimated $391K sold.

Jefferies Group first reported a position in NXTM in Q2 2015 and held it in 9 quarters. The position peaked at $3.82M in Q3 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Jefferies Group reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Jefferies Group sold 13,666 NxStage Medical Inc. shares in Q1 2019, an estimated $391K.
  • Jefferies Group first reported a position in NxStage Medical Inc. in Q2 2015 and held it in 9 quarters.
  • Jefferies Group's NxStage Medical Inc. position peaked at $3.82M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Jefferies Group's 13F filing for Q1 2019, filed 15 May 2019.